- News Home
27 November 2013 12:59 pm ,
Vol. 342 ,
The new head of the National Center for Science Education promises to "fight the good fight" against attacks on...
Analyses of the H7N9 strains isolated from four new cases show that the virus is evolving rapidly, heightening anxiety...
In 2009, Jack Szostak shared a Nobel Prize for his part in discovering the role of telomeres, the end bits of...
Science has exposed a thriving academic black market in China involving shady agencies, corrupt scientists, and...
Paper-selling agencies flourish in the aura of reputable businesses. For some scientists, it may be difficult to tell...
Featuring the first lunar rover in 40 years, Chang'e-3 is seen as an important milestone on China's quest to send a...
Data collected by satellites and floating probes have chronicled a 2-decade rise in the temperature and thickness of a...
Cholesterol, the artery-clogging molecule that contributes to cardiovascular disease, has another nasty trick up its...
- 27 November 2013 12:59 pm , Vol. 342 , #6162
- About Us
Cholera Vaccine Protects in Vietnam
24 January 1997 (All day)
An inexpensive cholera vaccine has performed well in a pilot trial in Vietnam. The finding, reported in tomorrow's issue of The Lancet, is a big advance in the long and frustrating search in developing countries for a useful vaccine against cholera, a potentially fatal illness spread through contaminated drinking water.
In late 1992, a team led by researchers at the National Institute of Hygiene and Epidemiology in Hanoi, Vietnam, and the U.S. National Institute of Child Health and Human Development gave the oral vaccine--which consists of killed whole Vibrio cholerae, the cholera bacterium--to more than 67,000 residents of Hue, Vietnam. A roughly equal number did not receive the vaccine. During 1993, 37 vaccinated people were admitted to a hospital with cholera, compared to 92 cases in the control group. Thus the vaccine decreased hospital admissions for cholera by 60%.
Developed and produced at the institute in Hanoi, the vaccine is relatively cheap to produce and is easy to distribute because it remains active without refrigeration. It also appears to be equally effective in children and adults. This surprised the researchers, because a similar whole, killed vaccine tested in Bangladesh in the 1980s appeared to be less potent in children.
"This study is important," says Myron M. Levine, director of the Center for Vaccine Development at the University of Maryland School of Medicine, "because it demonstrates that a developing country can design, produce, and evaluate a moderately effective vaccine in a large field trial with little external assistance."
The researchers plan to launch a larger trial in Vietnam later this year pitting the vaccine against a placebo. If proven effective, the vaccine could be pressed into duty quickly in Vietnam, where more than 3000 people get cholera each year. Levine adds that a similar vaccine against other cholera strains could be produced in developing countries such as Zaire, where an outbreak killed 12,000 people in Rwandan refugee camps in July 1994.